Previous 10 | Next 10 |
LEADING CANCER CENTRE PUBLISHES PARSORTIX WORKFLOW ADDRESSING PROBLEMS WITH ALTERNATIVE APPROACHES Workflow for RNA gene expression demonstrated in prostate cancer Researchers show that "previously undetectable prostate specific transcripts become readily measurable" GUIL...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Analysis supports ensifentrine’s efficacy in COPD as monotherapy and on top of standard of care treatment in patients who remain symptomatic Six abstracts accepted demonstrating ensifentrine’s potential across treatment settings and formulations LONDON, May 01, 2020 ...
For immediate release 1 May 2020 Serabi Gold plc (“Serabi” or the “Company”) Total Voting Rights Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focused gold mining a...
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 1, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines notes the recent movement in its share price and the Company confirms that it knows of n...
Reported positive Phase 2b results in symptomatic patients with moderate to severe COPD with nebulized ensifentrine Reported positive efficacy and safety with single dose pMDI ensifentrine U.S. FDA response to End-of-Phase 2 package expected in the second quarter Confere...
Calgary, Alberta and Houston, Texas--(Newsfile Corp. - April 29, 2020) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company ") advises that, due to the impact of the global COVID-19 pandemic, it is necessary to delay its 2019 year-end corporate filings, as pro...
DIDCOT, UK / ACCESSWIRE / April 29, 2020 / Altus Strategies Plc (AIM:ALS & TSX-V:ALTS), the Africa focused project and royalty generator, announces that it has published its Management Discussion and Analysis for the quarter and year ended 31 December 2019. This document has been publish...
DIDCOT, UK / ACCESSWIRE / April 29, 2020 / Altus Strategies Plc (AIM:ALS)(TSXV:ALTS), the Africa focused project and royalty generator, announces its audited final results for the year ended 31 December 2019. These are presented below and are available (along with the Company's 2019 Annual R...
OCALA, FL / ACCESSWIRE / April 29, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today announced that CEO Thomas K. Equels is scheduled ...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...